Analystreport

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at FIX from a "neutral" rating to a "buy" rating. They now have a $575.00 price target on t

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com